Skip to main content

Carisma Therapeutics Inc.

CARMDelisted Dec 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001485003

Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Carisma Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
37
−15 vs. Q2 2024
Shares held
5.21M
−193.0K (−3.6%) vs. Q2 2024
Total value
$5.11M
−$3.09M (−37.7%) vs. Q2 2024
New holders
3
8 more added
Sold out
18
12 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CARM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 37 institutions
Q1 2021: 76 institutionsQ2 2021: 106 institutionsQ3 2021: 103 institutionsQ4 2021: 93 institutionsQ1 2022: 84 institutionsQ2 2022: 74 institutionsQ3 2022: 69 institutionsQ4 2022: 71 institutionsQ1 2023: 37 institutionsQ2 2023: 53 institutionsQ3 2023: 58 institutionsQ4 2023: 50 institutionsQ1 2024: 51 institutionsQ2 2024: 53 institutionsQ3 2024: 37 institutionsQ4 2024: 41 institutionsQ1 2025: 37 institutionsQ2 2025: 36 institutionsQ3 2025: 33 institutionsQ4 2025: 7 institutionsQ1 2026: 3 institutionsQ2 2026: 1 institution
Value heldQ3 2024: $5.11M
Q1 2021: $104.4MQ2 2021: $305.9MQ3 2021: $44.5MQ4 2021: $39.1MQ1 2022: $26.4MQ2 2022: $23.1MQ3 2022: $11.0MQ4 2022: $19.8MQ1 2023: $17.3MQ2 2023: $84.0MQ3 2023: $39.6MQ4 2023: $26.4MQ1 2024: $19.3MQ2 2024: $9.28MQ3 2024: $5.11MQ4 2024: $2.35MQ1 2025: $1.73MQ2 2025: $1.56MQ3 2025: $842.6KQ4 2025: $67.0KQ1 2026: $47.9KQ2 2026: $4
Institutions holding CARM and their total value by quarter
QuarterHoldersValue
Q2 20261$4
Q1 20263$47.9K
Q4 20257$67.0K
Q3 202533$842.6K
Q2 202536$1.56M
Q1 202537$1.73M
Q4 202441$2.35M
Q3 202437$5.11M
Q2 202453$9.28M
Q1 202451$19.3M
Q4 202350$26.4M
Q3 202358$39.6M
Q2 202353$84.0M
Q1 202337$17.3M
Q4 202271$19.8M
Q3 202269$11.0M
Q2 202274$23.1M
Q1 202284$26.4M
Q4 202193$39.1M
Q3 2021103$44.5M
Q2 2021106$305.9M
Q1 202176$104.4M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Carisma Therapeutics Inc.; share changes are against Q2 2024.

Institutions holding CARM in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc1,448,247$1.42M0.00%00.0%Unchanged
Trustees of the University of Pennsylvania1,252,107$1.23M4.36%00.0%Unchanged
TPG GP A, LLC561,442$551.1K0.01%−280,589−33.3%Reduced
Barclays PLC549,305$539.2K0.00%+549,290+3,661,933.3%Added
BlackRock, Inc.408,564$401.0K0.00%+408,564New
Geode Capital Management, LLC259,184$254.5K0.00%−24,224−8.5%Reduced
Renaissance Technologies LLC206,757$203.0K0.00%+67,397+48.4%Added
Millennium Management LLC142,522$139.9K0.00%−17,519−10.9%Reduced
State Street Corp85,106$83.5K0.00%00.0%Unchanged
Northern Trust Corp75,451$74.1K0.00%−148,907−66.4%Reduced
Wexford Capital LP34,861$34.2K0.01%+15,000+75.5%Added
Two Sigma Investments, LP34,141$33.5K0.00%+34,141New
Bridgeway Capital Management, LLC30,438$29.9K0.00%+1,474+5.1%Added
Empowered Funds, LLC30,438$29.9K0.00%+1,474+5.1%Added
Blodgett Wealth Advisors, LLC25,001$24.5K0.02%−499−2.0%Reduced
Qube Research & Technologies Ltd16,584$16.3K0.00%−15,068−47.6%Reduced
Stratos Wealth Partners, LTD.12,200$12.0K0.00%00.0%Unchanged
Bank of America Corp7,281$7.14K0.00%−34,988−82.8%Reduced
Morgan Stanley5,685$5.58K0.00%−16,083−73.9%Reduced
Federated Hermes, Inc.4,973$4.88K0.00%+1,661+50.2%Added
Tower Research Capital LLC (TRC)4,524$4.44K0.00%−11,563−71.9%Reduced
Catalyst Funds Management Pty Ltd3,900$3.83K0.00%00.0%Unchanged
Group One Trading, L.P.2,230$2.19K0.00%00.0%Unchanged
JPMorgan Chase & Co921$9040.00%00.0%Unchanged
FMR LLC736$7220.00%−35,109−97.9%Reduced
Bank & Trust Co525$5150.00%00.0%Unchanged
Capital Performance Advisors LLP500$4910.00%+500New
Peoples Bank250$2450.00%00.0%Unchanged
UBS Group AG218$2140.00%−6−2.7%Reduced
IFP Advisors, Inc206$2030.00%00.0%Unchanged
ORG Partners LLC200$1960.00%00.0%Unchanged
National Bank of Canada165$1620.00%+115+230.0%Added
Nisa Investment Advisors, LLC161$1580.00%+141+705.0%Added
Advisor Group Holdings, Inc.142$1390.00%00.0%Unchanged
Harbour Investments, Inc.37$360.00%00.0%Unchanged
Citigroup Inc10$100.00%−3,502−99.7%Reduced
McMahon Financial Advisors, LLC8$80.00%00.0%Unchanged
Goldman Sachs Group Inc0$00.00%−232,793−100.0%Sold out
Jane Street Group, LLC0$00.00%−159,879−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−75,501−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−73,323−100.0%Sold out
Centiva Capital, LP0$00.00%−54,500−100.0%Sold out
Paloma Partners Management Co0$00.00%−31,578−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−26,006−100.0%Sold out
Mirae Asset Global ETFs Holdings Ltd.0$00.00%−13,016−100.0%Sold out
Rhumbline Advisers0$00.00%−8,387−100.0%Sold out
Clear Street Markets LLC0$00.00%−5,210−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−1,996−100.0%Sold out
Macquarie Group Ltd0$00.00%−1,373−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−645−100.0%Sold out
New York State Common Retirement Fund0$00.00%−212−100.0%Sold out
Old Point Trust & Financial Services N A0$00.00%−125−100.0%Sold out
Signature Resources Capital Management, LLC0$00.00%−14−100.0%Sold out
Royal Bank of Canada0$00.00%−104−100.0%Sold out
CWM, LLC0$00.00%−48−100.0%Sold out
BlackRock Inc.––––Not filed